DataMeds AI, Inc. (MEDS)
3.04
-0.31
(-9.25%)
USD |
NASDAQ |
Oct 06, 16:00
3.06
+0.02
(+0.66%)
After-Hours: 20:00
DataMeds AI Cash from Operations (Quarterly) : -2.894M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.894M |
| March 31, 2026 | -3.413M |
| December 31, 2025 | -6.293M |
| September 30, 2025 | -1.135M |
| June 30, 2025 | -2.079M |
| March 31, 2025 | -1.347M |
| December 31, 2024 | -2.660M |
| Date | Value |
|---|---|
| September 30, 2024 | 1.326M |
| June 30, 2024 | 0.0778M |
| March 31, 2024 | 0.0312M |
| December 31, 2023 | -0.4621M |
| September 30, 2023 | 0.1129M |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| PD-Rx Pharmaceuticals, Inc. | -- |
| Acro Biomedical Co. Ltd. | -0.0105M |
| Stella Diagnostics, Inc. | -0.9776M |
| Interpace Biosciences, Inc. | 0.098M |
| Medical Marijuana, Inc. | 0.5945M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.2421M |
| Cash from Financing (Quarterly) | 5.541M |
| Free Cash Flow | -14.66M |
| Free Cash Flow Per Share (Quarterly) | -1.218 |
| Free Cash Flow to Equity (Quarterly) | -7.012M |
| Free Cash Flow to Firm (Quarterly) | -1.575M |
| Free Cash Flow Yield | -219.7% |